MoonLake Immunotherapeutics MLTX Switzerland — Long-Lived Assets

Other geography segments

Similar metrics at other companies

CMPRSWITZERLAND — Long-Lived Assets

$76.07M+15.0%

NVCRSwitzerland — Total long lived assets

$46.55M-7.8%

ALGNSwitzerland — Total long-lived assets

$197.75M-65.2%

LKQOther countries — Long-Lived Assets

$762M+5.0%

LKQUNITED STATES — Long-Lived Assets

$1.3B-16.5%

BDCChina — Long-Lived Assets

$41.5M+7.4%

Questions, answered.

What is MoonLake Immunotherapeutics's switzerland — long-lived assets?

MoonLake Immunotherapeutics (MLTX) reported switzerland — long-lived assets of $888K in Q1 2026.

How has MoonLake Immunotherapeutics's switzerland — long-lived assets changed year-over-year?

MoonLake Immunotherapeutics's switzerland — long-lived assets increased by 64.7% year-over-year, from $539K to $888K.

What does switzerland — long-lived assets mean?

This metric quantifies the total book value of non-current, tangible, and intangible assets held by the company within the specified geographic segment. These assets typically include property, plant, equipment, and other long-term investments essential for regional operations. It serves as a key indicator of the capital intensity and physical presence maintained by the company in that specific market.